Browsing Tag
Zydus Lifesciences
92 posts
Zydus Lifesciences achieves WHO prequalification for Leishmaniasis treatment, Miltefosine
Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has achieved a significant milestone in global healthcare…
February 24, 2024
Zydus Lifesciences gains FDA approval for Cyclophosphamide Capsules
Zydus Lifesciences Limited, a leading pharmaceutical company, has achieved a significant milestone by receiving final approval from the…
December 17, 2023
Zydus Lifesciences to launch Phase 2 Parkinson’s disease trial of ZYIL1
Zydus Lifesciences Limited, a globally recognized pharmaceutical company, has recently obtained the USFDA’s approval to commence Phase II…
December 17, 2023
Zydus Lifesciences bags FDA approval for Lacosamide Tablets in seizures
Zydus Lifesciences Limited, a prominent player in the pharmaceutical industry, has recently received final approval from the United…
December 16, 2023
Zydus Lifesciences gains FDA approval for Darunavir Tablets in HIV-1 treatment
Zydus Lifesciences Limited, a prominent name in the global pharmaceutical industry, has achieved a significant milestone with the…
December 15, 2023
Zydus Lifesciences, Daewoong Pharmaceutical forge US market alliance for Leuprolide Acetate
Zydus Worldwide DMCC, a wholly-owned subsidiary of Zydus Lifesciences Ltd., and South Korea’s Daewoong Pharmaceutical Co., Ltd. have…
December 11, 2023
Zydus Group’s Sentynl Therapeutics gains full control of Menkes Disease candidate CUTX-101
Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company under Zydus Lifesciences, Ltd., has finalized an agreement with Cyprium Therapeutics,…
December 6, 2023
Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets
Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States…
December 2, 2023
Torrent Pharmaceuticals to co-market Saroglitazar Mg with Zydus for liver health
Torrent Pharmaceuticals Limited and Zydus Lifesciences Limited announced a significant licensing and supply agreement to co-market Saroglitazar Mg,…
November 10, 2023
FDA approves ZITUVIMET by Zydus Lifesciences for Type 2 diabetes treatment
Zydus Lifesciences Limited has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval…
November 6, 2023